Biocon to merge biologics unit in $5.5 billion deal

📅 Published: December 6, 2025 | 📂 Category: Uncategorized

Biocon Ltd will acquire the remaining stake in Biocon Biologics from Serum Institute Life Sciences, Tata Capital Growth Fund II, Activ Pine LLP and Mylan Inc

Read more

📱 Share on WhatsApp 🌐 View Original Article

Leave a Reply

Your email address will not be published. Required fields are marked *